daunorubicin has been researched along with stilbenes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fox, BW; McGown, AT | 1 |
| Ahmad, KA; Clement, MV; Hanif, IM; Pervaiz, S | 1 |
| Barbier, P; Bourgarel-Rey, V; Boutonnat, J; Combes, S; Douillard, S; Fedorov, AY; Finet, JP; McLeer-Florin, A; Peyrot, V; Pierson, JT | 1 |
3 other study(ies) available for daunorubicin and stilbenes
| Article | Year |
|---|---|
Differential cytotoxicity of combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Daunorubicin; Drug Interactions; Drug Resistance; Leukemia P388; Mice; Stilbenes; Tumor Cells, Cultured; Vinca Alkaloids | 1990 |
Resveratrol inhibits drug-induced apoptosis in human leukemia cells by creating an intracellular milieu nonpermissive for death execution.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Daunorubicin; HL-60 Cells; Humans; Hydrogen Peroxide; Leukemia; Mitochondria; NADPH Oxidases; Oxidation-Reduction; Resveratrol; Stilbenes; Superoxides; Vincristine | 2004 |
Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins. Part 2.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Division; Cell Line; Cell Line, Tumor; Coumarins; Crystallography, X-Ray; Daunorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; G2 Phase; Humans; Mitoxantrone; Models, Molecular; Neoplasm Proteins; Stilbenes; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2011 |